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Calcineurin is a key protein phosphatase required for hyphal growth and virulence
in Aspergillus fumigatus, making it an attractive antifungal target. However, currently
available calcineurin inhibitors, FK506 and cyclosporine A, are immunosuppressive,
limiting usage in the treatment of patients with invasive aspergillosis. Therefore, the
identification of endogenous inhibitors of calcineurin belonging to the calcipressin
family is an important parallel strategy. We previously identified the gene cbpA as
the A. fumigatus calcipressin member and showed its involvement in hyphal growth
and calcium homeostasis. However, the mechanism of its activation/inhibition through
phosphorylation and its interaction with calcineurin remains unknown. Here we show that
A. fumigatus CbpA is phosphorylated at three distinct domains, including the conserved
SP repeat motif (phosphorylated domain-I; PD-I), a filamentous fungal-specific domain
(PD-II), and the C-terminal CIC motif (Calcipressin Inhibitor of Calcineurin; PD-III). While
mutation of three phosphorylated residues (Ser208, Ser217, Ser223) in the PD-II did
not affect CbpA function in vivo, mutation of the two phosphorylated serines (Ser156,
Ser160) in the SP repeat motif caused reduced hyphal growth and sensitivity to oxidative
stress. Mutational analysis in the key domains in calcineurin A (CnaA) and proteomic
interaction studies confirmed the requirement of PxIxIT motif-binding residues (352-
NIR-354) and the calcineurin B (CnaB)-binding helix residue (V371) for the binding of
CbpA to CnaA. Additionally, while the calmodulin-binding residues (442-RVF-444) did
not affect CbpA binding to CnaA, three mutations (T359P, H361L, and L365S) clustered
between the CnaA catalytic and the CnaB-binding helix were also required for CbpA
binding. This is the first study to analyze the phosphorylation status of calcipressin in
filamentous fungi and identify the domains required for binding to calcineurin.
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Introduction
Calcineurin (also known as protein phosphatase 2B) is an impor-
tant protein phosphatase essential for hyphal growth, devel-
opment, and virulence in Aspergillus fumigatus, making it an
attractive antifungal target (Steinbach et al., 2007). However, due
to direct immunosuppressive eﬀects, administration of currently
available calcineurin inhibitors, FK506 and cyclosporine A, for
the treatment of patients with invasive aspergillosis is not prac-
tical (Ho et al., 1996). Therefore, identiﬁcation of endogenous
inhibitors of calcineurin is important to more eﬀectively inhibit
calcineurin as part of future drug targeting strategies. One such
group of endogenous inhibitors are the regulators of calcineurin
(RCANs; RCAN1-3) or modulatory calcineurin-interacting pro-
teins (MCIPs; MCIP1-3) belonging to the calcipressin family of
proteins (Rothermel et al., 2003). This family is composed of key
regulators of calcineurin-NFAT signaling in diverse organisms,
ranging from the yeasts to humans (Kingsbury and Cunningham,
2000; Rothermel et al., 2003). Another group of scaﬀolding
proteins, Cain/Cabin-1 and A-kinase anchoring protein 79
(AKAP79), have also been identiﬁed to interact and inhibit cal-
cineurin function in a phosphorylation-dependent manner in
mammalian cells (Coghlan et al., 1995; Kashishian et al., 1998;
Lai et al., 1998). Despite the conservation of calcineurin from
the yeasts to human, the fungal homologs of the endogenous
mammalian calcineurin inhibitor Cabin 1/Cain have not yet been
identiﬁed.
How RCAN proteins precisely modulate calcineurin function
is debatable. Earlier reports in mammalian cells revealed that
RCAN1, one of the target genes of NFAT, binds to calcineurin
and inhibits its activity (Fuentes et al., 2000; Rothermel et al.,
2000), but more recent reports suggest that RCAN1 actually facil-
itates the activation of the calcineurin-NFAT signaling pathway
(Sanna et al., 2006). A study using a combination of in silico
stimulations and single cell experiments indicated that RCAN1
inhibits calcineurin at lower concentrations, but functions as
a facilitator when its levels increase within the cell (Shin et al.,
2011).
Attempts to understand the molecular mechanism responsible
for facilitation of calcineurin-NFAT signaling revealed that phos-
phorylation of RCAN1 switches it from an inhibitor to a facili-
tator (Shin et al., 2011). Earlier structural analysis of domains in
RCAN1 revealed the requirement of PxIxIT and LxVP motifs in
order to cause an inhibitory eﬀect, and TxxP and ExxP motifs and
a GSK3β phosphorylation site to act as a facilitator (Mehta et al.,
2009). The hallmark of the members of the calcipressin family
is the presence of a conserved serine-proline repeat (SP repeat;
FxISPPxSPP motif) which is phosphorylated at the two ser-
ine residues by mitogen-activated kinase (MAPK), followed by
glycogen synthase kinase 3 (GSK3β; Vega et al., 2002). Studies
in Saccharomyces cerevisiae have shown that phosphorylation by
GSK3β within the SP repeat is required for calcineurin activity
(Hilioti et al., 2004). Previously, this GSK3β phosphorylation was
shown to be reversed by the phosphatase action of calcineurin
(Vega et al., 2002).
In the yeast S. cerevisiae, deletion of RCAN1 caused sensi-
tivity to cation stress, as opposed to no cation sensitivity with
deletion of CBP1 (the RCAN1 ortholog) in Cryptococcus neo-
formans (Görlach et al., 2000). In the presence of the FK506-
FKBP12 complex, binding of CBP1 to calcineurin was also
inhibited in C. neoformans (Görlach et al., 2000). In addi-
tion to the coordinating role of Cbp1 with calcineurin in
ﬁlamentation of C. neoformans during mating, the impor-
tance of phosphorylation and dephosphorylation of two serine
residues in the SP repeat motif for directing activity of cal-
cineurin during hyphal elongation was demonstrated through
site-directed mutagenesis (Fox and Heitman, 2005). In S. cere-
visiae, phosphorylation of RCAN1 promoted its degradation
and decreased its inhibitory eﬀect on calcineurin (Kishi et al.,
2007).
We previously demonstrated the importance of the RCAN1
ortholog, CbpA, for hyphal growth and calcium homeostasis
in A. fumigatus (Pinchai et al., 2009). While deletion of cbpA
resulted in increased expression of the vcxA (vacuolar Ca2+/H+
exchanger), chsA (chitin synthase A), and cnaA genes, it only
slightly attenuated virulence. Although we showed that cbpA
deletion or overexpression altered cnaA transcriptional response,
the biochemical mechanisms underlying A. fumigatus CbpA
phosphorylation and the mechanism of how it binds to cal-
cineurin remain unknown. In this study, using phosphopeptide
enrichment and tandem mass spectrometry we identiﬁed that
CbpA is phosphorylated at three distinct domains, including a
conserved SP repeat motif, a non-conserved ﬁlamentous fungal-
speciﬁc domain, and a C-terminal region with low homology
to yeast and human orthologs. Assessment of CbpA phospho-
rylation status in the absence of CnaA in vivo revealed the
continual phosphorylation of the two serine residues (Ser156,
Ser160) in the SP repeat motif and the two serine residues
(Ser217, Ser223) in the ﬁlamentous fungal-speciﬁc domain, indi-
cating the probable role for calcineurin in the dephosphorylation
of these residues. While mutation of the phosphorylated residues
in the non-conserved ﬁlamentous fungal-speciﬁc domain did
not result in any growth defects, mutations in the SP repeat
motif caused decreased hyphal growth and caused sensitivity
to oxidative stress. Furthermore, although we could not iden-
tify a consensus PxIxIT motif in A. fumigatus CbpA, we found
the absolute requirement of PxIxIT motif-binding residues (352-
NIR-354) and the calcineurin B (CnaB)-binding helix residue
(V371) for the binding of CbpA to CnaA. The binding of CbpA to
CnaA was not inhibited by mutation of the calmodulin-binding
residues (442-RVF-444) in CnaA, indicating that CbpA binds to
calcineurin independent of calmodulin. We also identiﬁed three
residues (T359, H361, and L365) that are clustered between the
catalytic and the CnaB-binding helix that are required for CbpA
binding.
Materials and Methods
Strains and Culture Conditions
Aspergillus fumigatus strain akuBKU80 and the isogenic pyrG aux-
otrophic strain akuBKU80 pyrG− were used in all experiments.
A. fumigatus cultures were grown on glucose minimal medium
(GMM) at 37◦C. Escherichia coliDH5α competent cells were used
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for subcloning. A. fumigatus was transformed as described earlier
(Steinbach et al., 2006). For radial growth analyses, 104 conidia
of the akuBKU80 and the other strains were cultured on GMM
agar at 37◦C, with colony diameters determined every 24 h over
a period of 5 days. All growth experiments were performed in
triplicate.
Generation of cbpA Deletion and
CbpA-EGFP Expression Strains
While a cbpA strain was previously reported by our group
(Pinchai et al., 2009), we generated a second deletion strain in
the akuBKU80 background for this study in order to maintain
the same genetic background for all mutated strains. Deletion of
cbpA was performed using a previously designed construct in the
plasmid pJW24 with the Aspergillus parasiticus pyrG gene as the
auxotrophic marker (Steinbach et al., 2006). The cbpA deletion
construct contained 1 kb promoter and 780 bp terminator ﬂank-
ing regions to facilitate homologous recombination. The ∼5 kb
cbpA deletion construct was PCR-ampliﬁed using the primers
cbpA-promo-KpnI-F and cbpA-term-HindIII-R (Supplementary
Table S1) and transformed into the A. fumigatus akuBKU80 pyrG−
strain. Transformants selected in the absence of uracil/uridine
(Steinbach et al., 2006) were screened by PCR (Supplementary
Table S1) and Southern analyses to conﬁrm deletion of the cbpA
gene (Supplementary Figure S1).
In order to purify the CbpA protein for phosphorylation
analyses, the cbpA-tagged egfp expression construct at the cbpA
native locus was generated by a fusion PCR strategy. First,
the 864 bp cbpA genomic DNA without the stop-codon and
the 722 bp egfp gene were PCR-ampliﬁed separately. Next, the
two PCR fragments were combined and used as templates to
amplify the ﬁnal fusion PCR product containing the cbpA-
egfp fusion product, which was then digested with KpnI and
NotI to clone at the KpnI-NotI sites in pUCGH (gift from
Axel Brakhage) with the hygromycin B resistant gene (hph)
as the selection marker. The cloned cbpA genomic DNA was
sequenced to ensure accuracy (Primers listed in Supplementary
Table S1). To facilitate homologous recombination, the 780 bp
cbpA terminator region was cloned into the SbfI-HindIII sites
in pUCGH (Langfelder et al., 2001). The ﬁnal plasmid obtained
was designated as pUCGH-CbpA, and the entire construct was
linearized by KpnI-HindIII digestion to obtain a fragment of
∼6.7 kb. The linearized construct was then transformed into
the A. fumigatus akuBKU80 strain as previously described and
transformants selected by resistance to hygromycin B. The trans-
formants obtained were veriﬁed for homologous integration by
PCR and also by ﬂuorescent microscopy to visualize GFP ﬂuores-
cence.
Construction of cbpA Mutations
Site-directed mutation of phosphorylated residues in CbpA was
performed using primers listed in Supplementary Table S1 and
pUCGH-cbpA as a template. Brieﬂy, the ﬁrst PCR used comple-
mentary primers overlapping the regions to be mutated and the
respective primers at the opposite ends to amplify two PCR frag-
ments. Next, a fusion PCR was performed by using an equipro-
portional mixture of the two PCR fragments as a template and
amplifying the mutated PCR fragment using primers at the oppo-
site ends (Supplementary Table S1). Each fragment cloned into
pUCGH was sequenced to conﬁrm the respective mutation and
then linearized for homologous integration. The linearized con-
structs were transformed into the A. fumigatus akuBKU80 strain
as previously described and transformants selected by resis-
tance to hygromycin B. The transformants obtained were veriﬁed
for homologous integration by PCR and also by ﬂuorescent
microscopy to visualize GFP ﬂuorescence.
Protein Extraction and GFP-TrapR© Affinity
Purification
The A. fumigatus strain expressing the cbpA-egfp fusion con-
struct was grown in GMM liquid medium as shaking cultures
for 24 h at 37◦C. Cell extracts were prepared by homogenizing
the mycelia using liquid nitrogen in buﬀer A (50 mM Tris/HCl,
pH 7.5, 150 mM NaCl, 50 mM KCl, 0.01% Triton X-100, 1 mM
PMSF, and 1:100 protease inhibitor cocktail). Total cell lysate
was initially centrifuged at 5000 rpm to eliminate cell debris,
and clariﬁed by further centrifugation at 7000 rpm for 10 min
at 4◦C. The ﬁnal supernatant fraction was collected and pro-
tein content determined by Bradford assay. Total protein was
normalized to contain ∼10 mg protein in the sample before
GFP-Trap aﬃnity puriﬁcation (Chromotek). GFP-Trap R© resin
(35 μl) was equilibrated by washing three times in 500 μl ice-
cold dilution buﬀer (10 mM Tris-HCl pH 7.5, 150 mM NaCl,
0.5 mM EDTA, 1 mM PMSF, 1:100 Protease Inhibitory Cocktail)
according to the manufacturer instructions and resuspended
in 100 μl ice cold dilution buﬀer. The GFP-Trap R© resin sus-
pension was then mixed with total crude cell lysate containing
∼10 mg total protein and incubated at 4◦C by gentle agita-
tion for 2 h. The suspension was centrifuged at 2000 rpm for
10 min at 4◦C and the pelleted GFP-Trap R© resin was washed
once in 500 μl of ice-cold dilution buﬀer and then twice with
500 μl of wash buﬀer (10 mM Tris-HCl pH 7.5, 350 mM
NaCl, 0.5 mM EDTA, 1 mM PMSF, 1:100 Protease Inhibitory
Cocktail).
Sample Preparation for Mass Spectrometry
Protein-bound GFP-Trap R© resins were washed three times with
200 μl of 50 mM ammonium bicarbonate, pH 8.0, and sus-
pended in 30 μl 50 mM ammonium bicarbonate, pH 8.0, sup-
plemented with 0.1% Rapigest SF surfactant (Waters Corp).
Samples were reduced with 5 mM dithiothreitol for 30 min at
70◦C and free sulfhydryls were alkylated with 10 mM iodoac-
etamide for 45 min at room temperature. Proteolytic diges-
tion was accomplished by the addition of 500 ng sequencing
grade trypsin (Promega) directly to the resin, with incuba-
tion at 37◦C for 18 h. Supernatants were collected following
a 2 min centrifugation at 1000 rpm, acidiﬁed to pH 2.5 with
TFA, and incubated at 60◦C for 1 h to hydrolyze the remain-
ing Rapigest surfactant. Insoluble hydrolyzed surfactant was
cleared by centrifugation at 15,000 rpm for 5 min. Ninety per-
cent (by volume) of the sample was then removed for sub-
sequent phosphopeptide analysis, and the remaining 10% (by
volume) was subjected to an unbiased protein interaction anal-
ysis.
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Phosphopeptide Enrichment and LC-MS/MS
Analysis
For the phosphopeptide analysis, samples were lyophilized to
dryness using vacuum centrifugation and resuspended in 65 μl
80% acetonitrile, 1% TFA. Peptides were subjected to phospho-
peptide enrichment using a 10 μl GL Sciences TiO2 Spin Tip and
subsequently washed with 80% acetonitrile, 1% TFA. Peptides
were eluted in 50 μl 20% acetonitrile, 5% aqueous ammonia,
pH 10.5, and then acidiﬁed to pH 2.5 with formic acid prior to
lyophilization to dryness.
Samples were resuspended in 10 μl 2% acetonitrile, 10 mM
citric acid 0.1% formic acid and subjected to chromatographic
separation on a Waters NanoAquity UPLC equipped with a
1.7 μm HSS T3 C18 75 μm I.D. x250 mm reversed-phase col-
umn. Phosphopeptide enriched samples were additionally sup-
plemented with 10 mM citric acid. The mobile phase consisted of
(A) 0.1% formic acid in water and (B) 0.1% formic acid in ace-
tonitrile. Following a 5 μl injection, peptides were trapped for
5 min on a 5 μm Symmetry C18 180 lm I.D. x20 mm column
at 20 μl/min in 99.9% A.
The analytical column was connected to a fused silica
PicoTip emitter (New Objective, Cambridge, MA, USA) with
a 10 μm tip oriﬁce. Non-phosphopeptide enriched samples
were analyzed on a Synapt G2 QToF mass spectrometer oper-
ating in a data-dependent mode of acquisition with a precur-
sor MS scan from m/z 400–2000 followed by three MS/MS
scans at a CID energy of 30% and a dynamic exclusion of
30 s. Phosphopeptide enriched samples were analyzed on a
QExactive Plus mass spectrometer with a precursor MS scan
from m/z 300–1600 with r = 70,000 at m/z 200 and a target
AGC setting of 1e6 ions. In a data-dependent mode of acqui-
sition, MS/MS spectra of the 10 most abundant precursor ions
were with a CID energy setting of 27 and a dynamic exclu-
sion of 20 s was employed for previously fragmented precursor
ions.
Raw LC-MS/MS data ﬁles were processed in Mascot distiller
(Matrix Science) and then submitted to independent Mascot
searches (Matrix Science) against a custom NCBI_Aspergillus
database containing both forward and reverse entries of each
protein. Search tolerances were 5 or 10 ppm for precursor
ions and 0.02 or 0.04 Da for product ions using trypsin
speciﬁcity with up to two missed cleavages for phosphopep-
tide enriched or non-phosphopeptide enriched data, respec-
tively. Carbamidomethylation (+57.0214 Da on C) was set
as a ﬁxed modiﬁcation, whereas oxidation (+15.9949 Da
on M), deamidation (+0.98 Da on NQ), and phosphoryla-
tion (+79.98 Da on STY) were allowed. All searched spec-
tra were imported into Scaﬀold (v4.0, Proteome Software)
and scoring thresholds were set to achieve a protein false
discovery rate of 0% using the PeptideProphet algorithm.
Normalized spectral counts were used to estimate relative
protein abundances for interaction studies. This was accom-
plished by adjusting the sum of the selected quantitative
value for all proteins in the list within each MS sample to
the average of the sums of all MS samples present in the
experiment.
Results and Discussion
Aspergillus fumigatus CbpA is
phosphorylated at Three Domains, Including
the FxSPPxSPP Motif
As a ﬁrst step toward identifying the phosphorylation status of
CbpA in vivo we initially utilized the A. fumigatus strain express-
ing cnaA-egfp fusion construct considering the fact that CbpA
would co-purify with CnaA. As shown in Supplementary Table
S2, puriﬁcation of CnaA by GFP-Trap R© aﬃnity puriﬁcation and
phosphopeptide-enrichment (see Supplemental Materials and
Methods) led to the identiﬁcation of six phosphorylated residues
in CbpA (Ser156, Ser160, Thr205, Ser208, Ser217, Ser223). Next,
in order to validate this ﬁnding and more clearly verify the
phosphorylation status of A. fumigatus CbpA in vivo, a strain
expressing the cbpA–egfp fusion construct under the control of
its native promoter was generated in the akuBKU80 strain. The
CbpA–EGFP fusion protein was puriﬁed by GFP-Trap R© aﬃn-
ity puriﬁcation and subjected to protease digestion, followed
by phosphopeptide-enrichment and tandem mass spectrometry.
As shown in Table 1, a total of nine residues (Ser8, Thr133,
Ser156, Ser160, Ser208, Ser217, Ser223, Ser257, and Ser266) were
identiﬁed to be phosphorylated in A. fumigatus CbpA.
Based on the location of the majority of the phosphorylated
residues, they were classiﬁed into three diﬀerent domains: phos-
phorylated domain I (PD-I), phosphorylated domain II (PD-II),
and phosphorylated domain III (PD-III; Figure 1). While the
phosphorylation of the FxISPPxSPP motif in the PD-I (Ser156,
Ser160; Supplementary Figure S2) is well-known from mam-
malian and the yeast RCANs (Vega et al., 2002; Hilioti et al., 2004;
Abbasi et al., 2006), the identiﬁcation of three residues phospho-
rylated in PD-II (Ser208, Ser217, Ser223) seems to be speciﬁc
to A. fumigatus as this region was not conserved in the C. neo-
formans Cbp1 or in the Human MCIP1 (Figure 1). In addition,
phosphorylation of two serine residues (Ser257 and Ser266) in
PD-III, previously designated as the CIC motif (Calcipressin
Inhibitor of Calcineurin), was also noted. The calcineurin-
binding PxIxIT sequence (PSVVVH) together with the ELHA
sequence comprises the CIC motif and is conserved in all ver-
tebrate RCANs/MCIPs (underlined in Figure 1; Aubareda et al.,
2006; Mulero et al., 2007). Both the ELHA and PxIxIT sequences
are required for binding to calcineurin with high aﬃnity
(Martínez-Martínez et al., 2009; Mulero et al., 2009). As shown in
Supplementary Figure S3, the two serine residues (Ser156 and
Ser160) in the FxISPPxSPP motif (PD-I) are conserved in all
the ﬁlamentous fungi. The fungal orthologs, however, show less
conservation to mammalian RCAN in the ELHA and PxIxIT
domains (PD-III; Supplementary Figure S3). However, it is inter-
esting to note that phosphorylation of a conserved serine residue
was observed within the CIC (PD-III) motif of MCIP1 (Figure 1;
serine residue shown in white color) and the protein kinase CK2
was identiﬁed as the enzyme responsible for the phosphoryla-
tion to potentiate inhibition of NFATc signaling by disrupting
the calcineurin-NFATc interaction (Martínez-Høyer et al., 2013).
Although we do not have conservation of the ELHA or the
PSVVVH residues in the A. fumigatus CbpA CIC motif (PD-III),
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TABLE 1 | List of phosphorylated peptides identified in CbpA by LC-MS/MS analysis.
Phosphorylated peptides identified in CbpA (1) Position Ascore probability
(2) %
Max mascot ion
score in wild-type
(spectral counts; 3)
Max mascot ion
score in cnaA strain
(spectral counts; 3)
ADITTTS*PPHSLPQSPSFR 8 <50 51.1 (1)
IYFGEPT*PLLDEGRPK 133 >99 49.1 (2) 60.7 (2)
LFFIS*PPPS*PPHGWVMR 156, 160 100 79.0 (5) 90.5 (4)
TEQSAPVSGPVDPGTPMS*MSDEKR 208 >99 72.3 (3)
TGS*WPIAMS*GQR 217, 223 <50, >99 46.5 (3) 43.4 (3)
SSTLIYNPEDHGGSPGLPAVMVEDTTVDS*DDEDIEMMS*PIDMSVR 257, 266 <50, >99 44.7 (3)
(1) Phosphorylated residues in the respective peptides are indicated by an asterisk. Phosphorylated residues in the phosphorylated domain I (PD-I) and phosphorylated
domain II (PD-II) are colored red and green, respectively.
(2) Probability of residue specific phosphorylation localization determined from http://ascore.med.harvard.edu/
(3) Maximum ion scores were determined for each phosphorylated peptide within an individual sample. Spectral counts indicate total number of matching spectral
assignments to that particular phosphorylated species within the individual LC-MS/MS analysis.
FIGURE 1 | Clustal alignment of Aspergillus fumigatus CbpA (AfCbpA)
with Cryptococcus neoformans Cbp1 (Cncbp1) and Human MCIP1.
Conserved residues are indicated in asterisks. Arrows and residues shown in
red indicate the identified phosphorylation sites in CbpA. The respective
phosphorylated domains PD-I (in pink), PD-II (in yellow) and PD-III (in green) are
boxed. The ELHA and the PxIxIT motifs (PSVVVH) in MCIP1 are underlined. The
phosphorylated residue within the CIC-motif of Human MCIP1 (PD-III) is shown
in white color.
we do have the predicted CK2 target sequence (S/TxxE/D) within
the PD-III.
While phosphorylation at the CIC motif (PD-III) was also
suggested to be independent of the phosphorylation occur-
ring at the FxISPPxSPP motif (PD-I) of the RCANs, the
non-phosphorylated CIC (PD-III) caused increased NFATc
(Martínez-Høyer et al., 2013). The absence of PD-II domain in
the mammalian MCIP1, the non-conservation of the PD-III
domain in the fungal orthologs (Supplementary Figure S3), and
our recovery of PD-III phosphorylated CbpA from the wild-type
strain all suggest possible diﬀerential regulation of the fungal
Cbps through phosphorylation-dephosphorylation. In the future,
it will be interesting to examine the eﬀect of mutation of these
residues on CbpA toward the CnaA–CrzA (ortholog of NFAT)
interaction and activation.
Deletion of CnaA Caused Reduction in the
Phosphorylated Residues of CbpA
Previous studies have suggested the dephosphorylation of RCANs
by calcineurin (Fox and Heitman, 2005). In the mammalian
RCANs, phosphorylation of the two serine residues within the
FxISPPxSPP motif (PD-I; Ser108 and Ser112) occurs ﬁrst at
Ser112 through MAPK, which then triggers subsequent phospho-
rylation at Ser108 by GSK3β (Vega et al., 2002). The phospho-
rylated Ser108 can then be dephosphorylated by calcineurin. It
was also previously shown that alterations in the FxISPPxSPP
motif (PD-I) phosphorylation inﬂuence protein stability, with
mutation of the FxISPPxSPP leading to a more stable pro-
tein (Genesca et al., 2003). Genetic evidence from S. cerevisiae
suggests that phosphorylation of Ser108 by GSK3 can release
the inhibitory activity of RCAN and convert the protein to
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an activator of calcineurin, although the exact mechanism is
unknown (Hilioti et al., 2004). Also it is unknown whether the
phosphorylation at the CICmotif (PD-III) is subject to regulation
by calcineurin protein phosphatase activity.
Considering these data, and the rationale that absence of
calcineurin may inhibit dephosphorylation of the residues that
undergo calcineurin-mediated dephosphorylation, we next deter-
mined if any of the phosphorylated residues are targets for
calcineurin by deleting cnaA and monitoring the phosphoryla-
tion status of CbpA. The FxISPPxSPP residues (PD-I; Ser156,
Ser160; Figure 2) and Ser217 and Ser223 in the PD-II domain
remained phosphorylated, in addition to the single Thr133
residue (Table 1). In addition to the N-terminal Ser8 residue, the
Ser208 in the PD-II domain, and the residues in the CIC motif
(PD-III; Ser257, Ser266) were not phosphorylated in the cnaA
deletion background, indicating the possibility of calcineurin
involvement in the phosphorylation-dephosphorylation mecha-
nism of CbpA. Speciﬁcally, the residues in the FxISPPxSPPmotif
(PD-I) and the PD-II domain may be amenable for dephospho-
rylation by calcineurin.
Phosphorylation and Dephosphorylation of
CbpA at the FxSPPxSPP Motif (PD-I) is
Important for Proper Hyphal Growth and
Tolerance to Oxidative Stress
Phosphorylation of the FxISPPxSPP motif (PD-I) at both ser-
ine residues in C. neoformans Cbp1 was shown to be neces-
sary for its stability, activity, and regulation of hyphal elonga-
tion during mating (Fox and Heitman, 2005). Interestingly, the
phosphorylation of the FxISPPxSPP motif (PD-I) did not medi-
ate the binding of calcineurin to Cbp1 (Fox and Heitman, 2005).
In order to investigate the importance of phosphorylation of
A. fumigatus CbpA at the FxISPPxSPP motif (PD-I), we next
mutated the two phosphorylated residues within the FxISPPxSPP
motif to alanine and aspartic acid residues, respectively, to mimic
a non-phosphorylated state (cbpAmt-PD-I-2SA) and a constitu-
tively phosphorylated state (cbpAmt-PD-I-2SD). Radial growth
analyses of the strains under normal growth conditions over a
period of 5 days indicated a slower growth rate in the cbpAmt-PD-
I-2SA strain compared to the cbpAmt-PD-I-2SD strain (Figure 3).
Unexpectedly, thecbpA strain displayed a slightly better growth
rate than the cbpAmt-PD-I-2SA strain. Based on our previous
report (Pinchai et al., 2009), it is possible that the complete
deletion of cbpA induces higher expression of calcineurin or
inappropriate activation of calcineurin that can negatively aﬀect
growth. Although the cbpAmt-PD-I-2SD strain grew better than
the cbpAmt-PD-I-2SA strain, its growth was comparable to the
cbpA strain, indicating that both dephosphorylation and con-
tinued phosphorylation of CbpA at the two serine residues in the
FxISPPxSPP motif (PD-I) aﬀected its activity. A similar obser-
vation was made with C. neoformans Cbp1-phospho mimetic
expression, wherein mutation of both the serines to glutamic
acid abolished ﬁlamentation during mating, a phenotype also
observed with complete deletion of Cbp1 (Görlach et al., 2000).
Importantly, in contrast to the FxISPPxSPPmotif mutations (PD-
I), the mutation of the three phosphorylated residues in the PD-II
domain did not have any eﬀect on the growth under normal
conditions (Figure 3).
FIGURE 2 | Selected ion chromatogram of LFFI[pS]PPP[pS]PPHGWVMR (m/z [708.9892]2+) from A. fumigatus CbpA in the akuBKU80 (reference
strain) and the cnaA background strains.
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FIGURE 3 | (A) Radial growth of the reference strain (wild-type; akuBKU80), the
cbpA strain, and the respective CbpA phosphorylation mutation strains
(cbpAmt-PD-I-2SA; cbpAmt-PD-I-2SD and cbpAmt-PD-II-3SA) was assessed
over a period of 5-days at 37◦C on GMM agar medium. Growth of the strains at
3, 4, and 5 days are shown. A total of 1 × 104 conidia were spotted for each
strain. (B) Measurement of colony diameter of the strains over a period of
5 days. For radial growth quantification the strains were grown on GMM agar
medium in triplicate and values are depicted as average colony diameter.
In mammalian cells, increased levels of RCAN1 were found
to be protective against oxidative stress and suppress cell
growth. It is not known whether these features of RCANs are
a direct consequence of calcineurin inhibition or result from a
yet unidentiﬁed action of RCAN (Leahy and Crawford, 2000).
Furthermore, phosphorylation of the mammalian RCANs at the
FxISPPxSPP motif (PD-I) was correlated with an increase in
calcineurin-mediated transcriptional inhibition (Genesca et al.,
2003). Hence, in order to determine the role of phosphory-
lated CbpA in counteracting oxidative stress, the respective cbpA
mutant strains were assayed for growth in the presence of the
oxidative stress inducer paraquat (Figure 4). Based on pheno-
types observed under normal growth conditions, phosphoryla-
tion of CbpA at the FxISPPxSPP motif (PD-I) is important for
proper hyphal growth, but the phosphorylation at the PD-II
domain seemed unimportant for growth. Furthermore, both the
cbpAmt-PD-I-2SA and the cbpAmt-PD-I-2SD strains were sensi-
tive to oxidative stress induced by paraquat (Figure 4) and H2O2
(data not shown), indicating the importance of phosphorylation-
dephosphorylation of CbpA for counteracting oxidative stress
conditions. The possibility of other phosphatases regulating the
dephosphorylation of CbpA cannot be precluded.
CnaA Requires the PxIxIT-Binding Motif and
CnaB-Binding Helix But not the
CaM-Binding Helix for Binding to CbpA
It was previously demonstrated that binding of mammalian
RCANs to the calcineurin catalytic subunit (CnA) does not
interfere with binding of either calmodulin (CaM) or the cal-
cineurin regulatory subunit (CnB) to CnA (Vega et al., 2002).
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FIGURE 4 | The reference strain (wild-type; akuBKU80), the cbpA
strain, and the respective CbpA phosphorylation mutation strains
(cbpAmt-PD-I-2SA; cbpAmt-PD-I-2SD and cbpAmt-PD-II-3SA) were
cultured in the absence or presence of the oxidative stress inducer
paraquat (5 mM). Strains were grown for a period of 5-days on GMM agar
supplemented with the respective oxidative stress inducers at 37◦C. To
more clearly distinguish the susceptibility of the strains to oxidative stress
agents the respective strains were cultured in GMM liquid medium
supplemented with paraquat (5 mM) and light-microscopy photographs (×10
magnification) were taken after 48 h of growth at 37◦C. For liquid growth
assays 1 × 104 conidia of each strain were inoculated into 200 μl of GMM
in multi-well plate.
In fact, most data indicate that RCANs bind preferentially to
active calcineurin, suggesting that CaM binding facilitates RCAN
binding (Martínez-Martínez et al., 2009). However, in C. neofor-
mans it was shown that the regulatory subunit of calcineurin
is required for the binding of CBP1 to drugs that inhibit cal-
cineurin activity (cyclosporin A or FK506) and also disrupt
the CBP1/CNA interaction (Görlach et al., 2000), suggesting that
the site of CBP1 interaction with CNA overlaps with that of
immunophilins.
We previously generatedA. fumigatus strains harboring muta-
tions in key domains of CnaA (the PxIxIT-binding motif; CnaB
binding helix; CaM-binding domain) to understand their signif-
icance for calcineurin localization and function (Juvvadi et al.,
2013). All the respective cnaA mutated constructs were tagged
to egfp and veriﬁed for stable expression (Juvvadi et al., 2013).
Because there is no predictable PxIxIT motif in the A. fumi-
gatus CbpA, we utilized the A. fumigatus strain expressing
CnaA-NIRmt-AAA in which the PxIxIT motif-binding residues
(352-NIR-354; Asn352 Ile353 Arg354) are mutated to alanines
in CnaA to determine if the binding of CbpA to CnaA requires
the PxIxIT motif. As shown in Table 2, we found that mutation
of the PxIxIT motif-binding NIR residues in CnaA completely
abolished the binding of CbpA to CnaA. The binding of CbpA to
CnaA was also found to be dependent on CnaB binding to CnaA.
This was demonstrated by utilizing the A. fumigatus mutant
strains expressing CnaAmt-V371D and CnaA-THLmt-PLS con-
structs wherein the key CnaB-binding residue Val371 on CnaA
is mutated to aspartic acid (V371D) and three other residues
(THLmt-PLS; Thr359 His361 Leu365 mutated to Pro359 Leu361
Ser361, respectively) located close to the CnaB binding helix
completely inhibited the binding of CbpA to CnaA. Moreover,
treatment with FK506 also inhibited the binding of CnaA to
CbpA. Contrary to these ﬁndings, mutation of the CaM bind-
ing domain residues RVF (442-RVF-444; Arg442 Val443 Phe444
to alanines) on CnaA did not aﬀect the binding of CbpA to
CnaA. The strain expressing wild-type CnaA-EGFPwas used as a
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TABLE 2 | Binding analysis of CbpA to various mutated calcineurin A (CnaAs) in vivo.
Strains/treatment Interacted with CnaA Uniquely identified peptides (1) Normalized total
spectral counts (2)
Wild type + SQIESIAPLNSFSPLPSLR
LLDGQSLLNR
IYFGEPTPLLDEGRPK
EVHASDLAQALAQL
TGSWPIAMSGQR
7
Wild type + FK506 − − −
CnaA-NIRmt-AAA − − −
CnaA-RVFmt-AAA + SQIESIAPLNSFSPLPSLR
LLDGQSLLNR
IYFGEPTPLLDEGRPK
EVHASDLAQALAQL
TGSWPIAMSGQR
LLEAPHLDK
6
CnaA-V371D − − −
CnaA-THLmt-PLS − − −
(1) Total number of unique peptide sequences identified to CbpA within the corresponding LC-MS/MS analysis.
(2) Normalized spectral counts reported from Scaffold following adjusting the sum of the selected quantitative value for all proteins in the list within each MS sample to a
common value: the average of the sums of all MS samples present in the experiment.
comparative control to determine the CbpA peptides bound to
CnaA. The binding of CbpA peptides to CnaA were validated
in three independent experiments by mass spectrometry (Table 2
and Supplementary Table S3). Taken together, these results indi-
cated that CbpA binds to CnaA through a PxIxIT motif and
requires the binding of CnaB to CnaA. Although we could not
identify the PxIxIT motif in CbpA, it is possible that a PxIxIT-like
sequence (PVDPGT) close to the newly identiﬁed phosphory-
lated domain II (PD II) is responsible for binding to CnaA. Future
crystallization studies on the calcineurin-CbpA complex would
shed light on the role of each of these domains and the func-
tional motifs in the binding of CbpA to calcineurin. Furthermore,
detailed knowledge of the molecular mechanisms governing the
CbpA-calcineurin interaction may also prove useful in the ratio-
nal design of future immunosuppressant drugs.
A recent study using human cell lines identiﬁed the phospho-
rylation of a serine residue at the CIC motif in all the RCANs
(RCAN1, RCAN2, and RCAN3; Martínez-Høyer et al., 2013).
Through in vitro and in vivo phosphorylation assays, CK2 was
identiﬁed as the kinase phosphorylating this serine residue and
this phosphorylation enhanced the disruptive potential toward
the calcineurin-NFATc interaction. Interestingly, in the present
study, the serine (Ser257) along with another serine residue at
position 266 was identiﬁed to be phosphorylated the region span-
ning the CIC motif (PD-III) in A. fumigatus CbpA. In the future,
it will be interesting to examine the eﬀect of mutation of these
residues on CbpA toward the CnaA-CrzA interaction and acti-
vation. Taken together, our results indicate that phosphorylation
of CbpA at the FxISPPxSPP motif (SP repeat motif) is conserved
in ﬁlamentous fungi and this phosphorylation is important for
CbpA function in vivo. In addition, the binding of CbpA to CnaA
occurs via a PxIxIT motif and the CnaB binding helix is essential
for the interaction.
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